[Gnso-newgtld-wg] Package 6

Tue Jun 30 03:17:55 UTC 2020

Agreed, there is no consensus that "closed generics", however defined,
should be banned.  It is certain that the Board did not ban them, nor could
they.

[image: Logo]

Mike Rodenbaugh

address:

548 Market Street, Box 55819

San Francisco, CA 94104

email:

mike at rodenbaugh.com

phone:

+1 (415) 738-8087

On Mon, Jun 29, 2020 at 2:44 PM Marc Trachtenberg via Gnso-newgtld-wg <
gnso-newgtld-wg at icann.org> wrote:

> +1 to Paul.  Everyone does not agree with that position.
>
>
>
> *Marc H. Trachtenberg*
> Shareholder
> Greenberg Traurig, LLP | 77 West Wacker Drive | Suite 3100 | Chicago, IL
> 60601
> Tel 312.456.1020
>
> Mobile 773.677.3305
>
> trac at gtlaw.com | www.gtlaw.com
>
>
>
> [image: Greenberg Traurig]
>
>
>
> *From:* Gnso-newgtld-wg [mailto:gnso-newgtld-wg-bounces at icann.org] *On
> Behalf Of *McGrady, Paul D.
> *Sent:* Monday, June 29, 2020 4:41 PM
> *To:* Jeff Neuman <jeff.neuman at comlaude.com>; Cheryl Langdon-Orr <
> langdonorr at gmail.com>
> *Cc:* gnso-newgtld-wg at icann.org
> *Subject:* [Gnso-newgtld-wg] Package 6
>
>
>
> **EXTERNAL TO GT**
>
> Hi Jeff & Cheryl,
>
>
>
> I was under the impression that we were going to discuss Closed Generics
> again, but I see it is Package 6.  Is Closed Generics not on the agenda for
> upcoming calls?  If it is, how can we be doing the so-called “Can’t live
> with” exercise when the topic isn’t closed on the calls?
>
>
>
> Also, I see that the text indicates that the WG agrees the Board
> instituted a ban on them in the last round.  That is not what the Board
> resolution says – and in fact there was much discussion on the calls and
> chat about how “ban” does not apply.  There were three options:  (1) make a
> change to non-exclusive access, (2) maintain & defer to the next round, or
> (3) withdraw. Is there a way to make that section reflect the actual facts
> before we have to undertake the so-called “can’t live with” exercise? The
> way it is written now essentially takes the starting position of the part
> of the WG that wants to censor closed generics and implies everyone agrees
> with it. That isn’t the case.
>
>
>
> Best,
>
> Paul
>
>
>
>
>
> *Taft *
> */ *
> *Paul* *D. McGrady* / Partner
> Taft Stettinius & Hollister LLP
> 111 E. Wacker Drive, Suite 2800
> Chicago, Illinois 60601-3713
> Tel: 312.527.4000 • Fax: 312.754.2354
> Direct: 312.836.4094 • Cell: 312.882.5020
> *www.taftlaw.com
> <https://urldefense.com/v3/__http:/www.taftlaw.com__;!!DUT_TFPxUQ!WfZ003NwR5MlyrcrA5sNQIVRi1CpK3G08B_AvVzpHfqM5jVengQwAujDpoyN2yGnx_E$> *
> / PMcGrady at taftlaw.com
>
> [image:
> https://dg01.redatatech.com/onprem_image_fetch?cid=1016&ep=2b8abf60503911b866966ee411c730b1e093feb7b3f8954ff3befe67d974b213381dc07c341ce027648cb0af8129a9e994a0818231199c14d6fdfe92692ed886cba1fe3d826783ee9a653dcca5732a24ad509dcbe02154dbdbb9334888f9d0fa00569bb98ef66cc7a9f840bd1c009a2fe2e4bc5a33e46f8dfefceb66aa514cd14acea9811e5318f31cc882393e7f7ee5fa019ab16969286fb371e26039327bf37555b04de9825b7b4f4266189ec80036b325a44d4ffdab50a15507915fc7a1249f04a870881fe14c500c47a61d98b1e86a0d93b9444746b9]
>
> *Taft Bio
> <https://urldefense.com/v3/__http:/www.taftlaw.com/bio/PMcGrady@taftlaw.com__;!!DUT_TFPxUQ!WfZ003NwR5MlyrcrA5sNQIVRi1CpK3G08B_AvVzpHfqM5jVengQwAujDpoyNa1Ial7E$>*
>
> [image: V-Card Icon]
>
> *Taft vCard
> <https://urldefense.com/v3/__http:/www.taftlaw.com/vcard/PMcGrady@taftlaw.com__;!!DUT_TFPxUQ!WfZ003NwR5MlyrcrA5sNQIVRi1CpK3G08B_AvVzpHfqM5jVengQwAujDpoyN9rmjG_8$>*
>
>
> Subscribe to our law updates
> <https://urldefense.com/v3/__http:/taftlaw.com/news/subscribe__;!!DUT_TFPxUQ!WfZ003NwR5MlyrcrA5sNQIVRi1CpK3G08B_AvVzpHfqM5jVengQwAujDpoyNc0ejsHA$>
>
>
>
>
>
>
>
> To receive regular COVID-19 updates from Taft, subscribe here
> <https://urldefense.com/v3/__https:/www.taftlaw.com/general/subscribe__;!!DUT_TFPxUQ!WfZ003NwR5MlyrcrA5sNQIVRi1CpK3G08B_AvVzpHfqM5jVengQwAujDpoyNvUCd2HU$>.
> For additional resources, visit Taft's COVID-19 Resource Toolkit
> <https://urldefense.com/v3/__https:/www.taftlaw.com/general/coronavirus-covid-19-resource-toolkit__;!!DUT_TFPxUQ!WfZ003NwR5MlyrcrA5sNQIVRi1CpK3G08B_AvVzpHfqM5jVengQwAujDpoyNchkgzIY$>
> .
>
> This message may contain information that is attorney-client privileged,
> attorney work product or otherwise confidential. If you are not an intended
> recipient, use and disclosure of this message are prohibited. If you
> received this transmission in error, please notify the sender by reply
> e-mail and delete the message and any attachments.
>
>
> ------------------------------
> If you are not an intended recipient of confidential and privileged
> information in this email, please delete it, notify us immediately at
> postmaster at gtlaw.com, and do not use or disseminate the information.
> _______________________________________________
> Gnso-newgtld-wg mailing list
> Gnso-newgtld-wg at icann.org
> https://mm.icann.org/mailman/listinfo/gnso-newgtld-wg
> _______________________________________________
> By submitting your personal data, you consent to the processing of your
> personal data for purposes of subscribing to this mailing list accordance
> with the ICANN Privacy Policy (https://www.icann.org/privacy/policy) and
> the website Terms of Service (https://www.icann.org/privacy/tos). You can
> visit the Mailman link above to change your membership status or
> configuration, including unsubscribing, setting digest-style delivery or
> disabling delivery altogether (e.g., for a vacation), and so on.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mm.icann.org/pipermail/gnso-newgtld-wg/attachments/20200629/819d2b9f/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.jpg
Type: image/jpeg
Size: 6399 bytes
Desc: not available
URL: <http://mm.icann.org/pipermail/gnso-newgtld-wg/attachments/20200629/819d2b9f/image001-0001.jpg>